AFC-HD AMS Life Science Co.,Ltd.JP:2927

Market cap
¥12.4B
P/E ratio
8.3x
2011/082012/082013/082014/082015/082016/082017/082018/082019/082020/082021/082022/082023/082024/082025/08
Revenue14,65414,79514,36613,72814,41514,63115,14215,79616,25315,81922,36822,99725,57930,18532,655
Cost of revenue---9,61610,15410,24110,53411,20311,73211,26515,50314,41816,25619,69421,394
Gross profit---4,1124,2614,3904,6084,5934,5214,5556,8658,5799,32310,49211,261
Gross margin (%)---
Operating income ---5659518911,0691,0239811,0942,2451,0111,6361,9162,410
Operating expenses ---3,5483,3103,4993,5393,5693,5403,4614,6207,5687,6878,5768,852
Income before tax 9966748185088928121,0409821,0151,1002,1621,3431,6541,9212,444
Provision for income taxes---211356269171249308328662498439665732
Net income 4905695722836064904667377836771,4967381,1071,2521,469
Earnings per share41.1347.7448.1423.8250.6440.4738.4858.2855.748.12107.1252.3378.5189.2102.98
Diluted EPS41.12--23.485040.34----106.352.0878.4689.11102.97
Dividend payout ratio (%)----------
Dividend per share15010151015151020252027.53027.53034